عنوان
پدید آورنده
موضوع
رده
RC377 .M85 2003eb
RC377
.
M85
2003eb
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
0203639111
(Number (ISBN
1135414025
(Number (ISBN
1135414068
(Number (ISBN
1135414076
(Number (ISBN
9780203639115
(Number (ISBN
9781135414023
(Number (ISBN
9781135414061
(Number (ISBN
9781135414078
Erroneous ISBN
1841842265
Erroneous ISBN
9781841842264
NATIONAL BIBLIOGRAPHY NUMBER
Number
b727279
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Multiple sclerosis therapeutics /
General Material Designation
[Book]
First Statement of Responsibility
edited by Jeffrey A. Cohen, Richard A. Rudick ; prefaces written by Henry McFarland.
EDITION STATEMENT
Edition Statement
2nd ed.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
New York :
Name of Publisher, Distributor, etc.
Martin Dunitz,
Date of Publication, Distribution, etc.
2003.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (xxiii, 754 pages) :
Other Physical Details
illustrations
GENERAL NOTES
Text of Note
Previous edition: 1999.
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
""Book Cover""; ""Half-Title""; ""Title""; ""Copyright""; ""Contents""; ""Contributors""; ""Preface to First Edition""; ""Preface to Second Edition""; ""Acknowledgements""; ""I Introduction""; ""1 Aspects of multiple sclerosis that relate to clinical trial design and treatment ""; ""II Clinical trial methodology""; ""2 Measures of neurologic impairment and disability in multiple sclerosis""; ""3 Assessment of neuropsychological function in multiple sclerosis""; ""4 Health-related quality of life assessment in multiple sclerosis""
Text of Note
""13 Ethical considerations in multiple sclerosis clinical trials""""14 The process of drug development and approval in the USA, the European Union, and Canada""; ""15 Sponsors, monitoring committees and investigators: the investigator�s perspective""; ""16 Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: reporting extended results from phase III clinical trials""; ""17 The failed clinical trial in multiple sclerosis""
Text of Note
""18 The challenge of long-term studies in multiple sclerosis: use of pooled data, historical controls, and observational studies to determine efficacy""""19 Emerging concepts of pathogenesis: relationship to therapies for multiple sclerosis""; ""III Clinical trials of disease-modifying therapy""; ""33 Complementary and alternative treatments in multiple sclerosis""; ""32 Sex hormones and other pregnancy-related factors with therapeutic potential in multiple sclerosis""; ""31 Combination therapies in multiple sclerosis""; ""30 Emerging disease-modifying therapies for multiple sclerosis""
Text of Note
""29 Treatment of multiple sclerosis by hematopoietic stem cell transplantation""""28 Cyclophosphamide treatment of multiple sclerosis""; ""27 Treatment of multiple sclerosis with methylprednisolone""; ""26 Therapeutic plasma exchange for multiple sclerosis""; ""25 Intravenous immunoglobulin to treat multiple sclerosis""; ""24 Use of mitoxantrone to treat multiple sclerosis""; ""23 Glatiramer acetate as therapy for multiple sclerosis""; ""22 Biological responses to type I interferons: relationship to therapeutic effects in multiple sclerosis""
Text of Note
""5 Magnetic resonance imaging in multiple sclerosis: an overview""""6 Measures of gadolinium enhancement in multiple sclerosis ""; ""7 Measures of magnetization transfer in multiple sclerosis""; ""8 Measures of T1 and T2 relaxation in multiple sclerosis""; ""9 Measurement of central nervous system atrophy""; ""10 Measures to quantify axonal damage in vivo based on magnetic resonance spectroscopy in multiple sclerosis""; ""11 Functional imaging in multiple sclerosis""; ""12 Use of cost analyses to improve understanding of the therapeutic trade-offs for multiple sclerosis""
0
8
8
8
8
ACQUISITION INFORMATION NOTE
Source for Acquisition/Subscription Address
Informa Healthcare
Stock Number
9780203639115
OTHER EDITION IN ANOTHER MEDIUM
Title
Multiple sclerosis therapeutics.
International Standard Book Number
1841842265
TOPICAL NAME USED AS SUBJECT
Multiple sclerosis-- Treatment.
Multiple sclerosis.
Clinical Trials-- methods
Magnetic Resonance Imaging.
Multiple Sclerosis-- pathology.
Multiple Sclerosis-- therapy.
Outcome Assessment, Health Care.
HEALTH & FITNESS-- Diseases-- Alzheimer's & Dementia.
MEDICAL-- Neurology.
Multiple sclerosis-- Treatment.
Multiple sclerosis.
(SUBJECT CATEGORY (Provisional
HEA-- 039140
MED-- 056000
DEWEY DECIMAL CLASSIFICATION
Number
616
.
83406
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC377
Book number
.
M85
2003eb
OTHER CLASS NUMBERS
Class number
2003
C-127
Class number
WL
360
Book Number
M9596
2003
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Cohen, Jeffrey A., (Jeffrey Alan),1954-
Rudick, Richard A.
ORIGINATING SOURCE
Date of Transaction
20201213234909.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
